Neoplasm Treatment - Lesotho
Lesotho- in Lesotho, a country in southern Africa, is also a part of the Neoplasm Treatment market.
- It is projected that the revenue in this market will reach US$7.15m in 2024.
- Looking ahead, there is an expected annual growth rate (CAGR 2024-2029) of 4.70%, which will result in a market volume of US$9.00m by 2029.
- It is important to note that in global comparison, United States is expected to generate the highest revenue in this market, with an estimated amount of US$90.56bn in 2024.
- Lesotho's neoplasm treatment market is seeing a rise in demand for advanced therapies and personalized medicine.
Definition:
Neoplasm Treatment refers to the medical and surgical treatments of cancer patients who require hospitalization for their care. This includes surgeries, chemotherapy, radiation therapy, immunotherapy, and/or other treatments that require close monitoring and support from healthcare professionals. Patients will typically stay in a hospital for several days to several weeks, depending on the severity of their condition. This allows hospitals to provide the highest level of medical support and to help manage symptoms and/or side effects of the patients while they receive treatment.
Additional information:
The Neoplasm Treatments market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient treatment of cancer patients
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
